北陆药业
(300016)
| 流通市值：22.99亿 | | | 总市值：23.02亿 |
| 流通股本：4.91亿 | | | 总股本：4.92亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 207,506,078.84 | 890,718,122.26 | 649,819,616.22 | 438,031,070.4 |
| 营业收入 | 207,506,078.84 | 890,718,122.26 | 649,819,616.22 | 438,031,070.4 |
| 二、营业总成本 | 191,504,388.32 | 947,665,868.11 | 675,045,224.45 | 444,329,462.64 |
| 营业成本 | 92,106,036.82 | 472,008,176.2 | 331,877,920.48 | 221,048,475.61 |
| 税金及附加 | 2,694,548.49 | 10,285,002.36 | 8,510,598.59 | 5,676,296.17 |
| 销售费用 | 52,046,830.73 | 217,045,570.56 | 154,423,679.33 | 102,195,362.95 |
| 管理费用 | 18,047,690.4 | 81,738,350.34 | 55,508,275.22 | 36,708,501.86 |
| 研发费用 | 13,889,933.57 | 122,328,869.24 | 86,346,507.94 | 53,697,728.82 |
| 财务费用 | 12,719,348.31 | 44,259,899.41 | 38,378,242.89 | 25,003,097.23 |
| 其中:利息费用 | 13,761,185.02 | 53,138,033.57 | 39,663,820.39 | 25,381,882.78 |
| 其中:利息收入 | 1,682,757.62 | 11,820,546.99 | 6,677,809.12 | 4,320,549.26 |
| 加:公允价值变动收益 | -3,683,666.3 | -13,956,107.18 | 9,191,715.22 | 6,542,648.46 |
| 加:投资收益 | 849,798.08 | 5,991,812.84 | 4,510,564.98 | 3,628,337.12 |
| 资产处置收益 | 1,818.3 | 894,314.78 | 866,108.95 | 866,108.95 |
| 资产减值损失(新) | -834,083.93 | -45,180,929.1 | -3,750,306.43 | -3,431,382.68 |
| 信用减值损失(新) | 879,631.06 | -3,833,964.77 | -1,756,085.24 | -1,709,386.14 |
| 其他收益 | 2,647,463.49 | 12,593,788.99 | 6,427,188.1 | 2,515,262.51 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 15,862,651.22 | -100,438,830.29 | -9,736,422.65 | 2,113,195.98 |
| 加:营业外收入 | 49,318.58 | 1,767,877.55 | 1,518,357.33 | 1,504,032.7 |
| 减:营业外支出 | 3,714.54 | 2,483,730.91 | 811,190.95 | 543,444.54 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 15,908,255.26 | -101,154,683.65 | -9,029,256.27 | 3,073,784.14 |
| 减:所得税费用 | 4,287,015.14 | -17,954,112.6 | -4,814,820.86 | -1,882,235.89 |
| 六、净利润 | 11,621,240.12 | -83,200,571.05 | -4,214,435.41 | 4,956,020.03 |
| 持续经营净利润 | 11,621,240.12 | -83,200,571.05 | -4,214,435.41 | 4,956,020.03 |
| 归属于母公司股东的净利润 | 11,526,165 | -71,757,140.03 | 1,941,694.1 | 9,601,525.49 |
| 少数股东损益 | 95,075.12 | -11,443,431.02 | -6,156,129.51 | -4,645,505.46 |
| (一)基本每股收益 | 0.02 | -0.15 | 0 | 0.02 |
| (二)稀释每股收益 | 0.04 | -0.07 | 0.05 | 0.05 |
| 九、综合收益总额 | 11,621,240.12 | -83,200,571.05 | -4,214,435.41 | 4,956,020.03 |
| 归属于母公司股东的综合收益总额 | 11,526,165 | -71,757,140.03 | 1,941,694.1 | 9,601,525.49 |
| 归属于少数股东的综合收益总额 | 95,075.12 | -11,443,431.02 | -6,156,129.51 | -4,645,505.46 |
| 公告日期 | 2024-04-22 | 2024-04-22 | 2023-10-27 | 2023-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |